首页 | 本学科首页   官方微博 | 高级检索  
     

miR-221通过调节PTEN影响肺癌细胞对吉非替尼的耐药性
引用本文:郑礼平,陈艺丹,张楠,全文,梁翠微,龚五星. miR-221通过调节PTEN影响肺癌细胞对吉非替尼的耐药性[J]. 中国病理生理杂志, 2019, 35(3): 454-458. DOI: 10.3969/j.issn.1000-4718.2019.03.001
作者姓名:郑礼平  陈艺丹  张楠  全文  梁翠微  龚五星
作者单位:珠海市人民医院, 暨南大学附属珠海医院肿瘤科, 广东 珠海 519000
基金项目:广东省珠海市医学科研基金资助项目(No.20181117A010052)
摘    要:
目的:探讨微小RNA-221(miR-221)在人肺癌细胞对吉非替尼耐药中的作用及其相关机制。方法:RT-qPCR检测人肺腺癌吉非替尼敏感细胞PC9和吉非替尼耐药细胞PC9/GR中miR-221的表达;通过脂质体试剂Lipofectamine 2000把miR-221 inhibitor转染入肺癌PC9/GR细胞内,CCK-8法检测细胞对吉非替尼敏感度的变化,Western blot检测第10号染色体缺失的磷酸酶及张力蛋白同源物(PTEN)的蛋白表达。构建含PTEN 3’-UTR的萤光素酶报告载体,验证miR-221对PTEN的靶向调控作用。结果:PC9/GR细胞的miR-221表达水平明显高于PC9细胞(P0.05)。PC9/GR细胞中PTEN表达水平低于PC9细胞(P0.05)。转染miR-221 inhibitor后,吉非替尼对PC9/GR细胞的IC_(50)明显降低,PTEN的蛋白表达增加(P0.05)。萤光素酶活性检测实验显示抑制miR-221表达能增强PTEN的萤光素酶活性(P0.05)。结论:miR-221可能通过抑制PTEN的表达,增强肺癌细胞对吉非替尼的耐药性。

关 键 词:肺癌  微小RNA-221  PTEN蛋白  吉非替尼  耐药性  
收稿时间:2018-05-22

miR-221 changes resistance of lung cancer cells to gefitinib by regulating PTEN
ZHENG Li-ping,CHEN Yi-dan,ZHANG Nan,QUAN Wen,LIANG Cui-wei,GONG Wu-xing. miR-221 changes resistance of lung cancer cells to gefitinib by regulating PTEN[J]. Chinese Journal of Pathophysiology, 2019, 35(3): 454-458. DOI: 10.3969/j.issn.1000-4718.2019.03.001
Authors:ZHENG Li-ping  CHEN Yi-dan  ZHANG Nan  QUAN Wen  LIANG Cui-wei  GONG Wu-xing
Affiliation:Department of Oncology, Zhuhai People's Hospital, Zhuhai Hospital Affiliated to Jinan University, Zhuhai 519000, China
Abstract:
AIM: To explore the effect of microRNA-221 (miR-221) on resistance of lung cancer cells to gefitinib, and to investigate its related mechanism. METHODS: RT-qPCR was used to detect the levels of miR-221 expression between gefitinib-sensitive cell line PC9 and gefitinib-resistant cell line PC9/GR. The PC9/GR cells were transfected with miR-221 inhibitor by Lipofectamine 2000. The drug sensitivity of these cells to gefitinib was determined by CCK-8 assay. The protein expression level of phosphatase and tensin homologue deleted on chromosome ten (PTEN) was determined by Western blot. The 3'-UTR of PTEN was cloned into luciferase reporter vector and its luciferase activity was detected to verify whether miR-221 targets PTEN. RESULTS: The expression level of miR-221 in the PC9/GR cells was significantly higher than that in the PC9 cells (P<0.05). The protein expression level of PTEN in the PC9/GR cells was lower than that in the PC9 cells (P<0.05). The IC50 of gefitinib was significantly reduced in the PC9/GR cells after transfection with miR-221 inhibitor (P<0.05). The protein expression level of PTEN in the cells transfected with miR-221 inhibitor was increased as compared with control group and blank group (P<0.05). Inhibition of miR-221 expression enhanced the enzymatic activity of luciferase reporter vector of PTEN. CONCLUSION: miR-221 enhances the resistance of lung cancer cells to gefitinib by down-regulating the protein expression of PTEN.
Keywords:Lung cancer  MicroRNA-221  PTEN protein  Gefitinib  Drug resistance
本文献已被 CNKI 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号